@article{82be3be12b43472db364476fb0409bea,
title = "The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction",
abstract = "An Expert Panel of the National Lipid Association reviewed the evidence related to the use of coronary artery calcium (CAC) scoring in clinical practice for adults seen for primary prevention of atherosclerotic cardiovascular disease. Recommendations for optimal use of this test in adults of various races/ethnicities, ages and multiple domains of primary prevention, including those with a 10-year ASCVD risk <20%, those with diabetes or the metabolic syndrome, and those with severe hypercholesterolemia were provided. Recommendations were also made on optimal timing for repeat calcium scoring after an initial test, use of CAC scoring in those taking statins, and its role in informing the clinician patient discussion on the benefit of aspirin and anti-hypertensive drug therapy. Finally, a vision is provided for the future of coronary calcium scoring.",
keywords = "Atherosclerotic cardiovascular disease risk prediction, Computed tomography, Coronary artery calcium scoring, Subclinical coronary atherosclerosis",
author = "Orringer, {Carl E.} and Blaha, {Michael J.} and Ron Blankstein and Budoff, {Matthew J.} and Goldberg, {Ronald B.} and Gill, {Edward A.} and Maki, {Kevin C.} and Laxmi Mehta and Jacobson, {Terry A.}",
note = "Funding Information: C.E.O. discloses that in the past 12 months, he has nothing to disclose. M.J.B. discloses that in the past 12 months, he has received research grants from the National Institute of Health, the U.S. Food and Drug Administration, the American Heart Association, the Aetna Foundation, and the Amgen Foundation. He has received advisory board honorarium from the Amgen Foundation, Sanofi, Regeneron, Novartis, Novo Nordisk, Bayer, Akcea and 89Bio. He has received consulting fee honorarium from Gilead. R.B. discloses that in the past 12 months, he has nothing to disclose. M.J.B. discloses that in the past 12 months, he has received speaking honorarium from Amarin and Amgen. R.B.G. discloses that in the past 12 months, he has nothing to disclose. E.A.G. discloses that in the past 12 months, he has nothing to disclose. K.C.M. discloses that in the past 12 months, he has received research grant support from Abbott, Acasti, Matinas Biopharma, Novo Nordisk, Pharmavite, Kellogg, General Mills, Hass Avocado Board, American Egg Board, Beef Checkoff, National Dairy Council, and American Potato Research & Education. He has received consulting fees from 89bio, BestMilk, and Matinas Biopharma. L.M. discloses that in the past 12 months, she has nothing to disclose. T.A.J. discloses that in the past 12 months, he has nothing to disclose. Publisher Copyright: {\textcopyright} 2020 National Lipid Association",
year = "2021",
month = jan,
day = "1",
doi = "10.1016/j.jacl.2020.12.005",
language = "English (US)",
volume = "15",
pages = "33--60",
journal = "Journal of clinical lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "1",
}